GAST
EstablishedGastrin is the key diagnostic marker for Zollinger-Ellison syndrome, complicated by common heartburn medications.
Gastrin is a stomach hormone that shoots up in a rare tumor called Zollinger-Ellison syndrome. Common heartburn medications can falsely raise gastrin too, which is tricky, because stopping those medications to get a clean test result can actually be dangerous for patients who truly have the tumor.
Gastrin is a hormone produced by G-cells in the stomach that stimulates gastric acid secretion; markedly elevated levels are the hallmark of Zollinger-Ellison syndrome (ZES), a rare gastrin-secreting neuroendocrine tumor (gastrinoma).
Fasting serum gastrin is the best single screening test for ZES, though in most patients gastrin alone (even combined with acid secretion studies) cannot establish the diagnosis, requiring provocative testing (secretin stimulation) in ambiguous cases.
A real diagnostic trap parallels chromogranin A: proton pump inhibitors cause false hypergastrinemia and can even produce false-positive secretin stimulation tests for ZES, with documented cases of patients wrongly worked up for a tumor because of their acid-reducing medication.
Stopping PPIs to get a clean gastrin reading is genuinely dangerous in patients who truly have ZES, since rebound acid hypersecretion has caused esophageal strictures and intestinal microperforation in reported cases — creating a real clinical tension between test accuracy and patient safety that current diagnostic approaches are actively navigating.
PPI-related false elevation creates real diagnostic and safety tension in confirming or excluding this rare tumor.
- Clinical Gastroenterology and Hepatology. (2011). The Zollinger-Ellison Syndrome: Dangers and Consequences of Interrupting Antisecretory Treatment.
- PMC. (2017). Diagnosis of Zollinger-Ellison syndrome in the era of PPIs.